Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.587604
Abstract: Alzheimer’s disease (AD) is a neurodegenerative disease that causes behavioral and cognitive impairments. The phytocannabinoid cannabidiol (CBD) has anti-inflammatory, antioxidant, and neuroprotective properties, and in vitro and limited in vivo evidence suggests that CBD possesses…
read more here.
Keywords:
treatment;
appxps1 mice;
mice;
medium dose ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.931384
Abstract: Cannabidiol is a promising potential therapeutic for neurodegenerative diseases, including Alzheimer’s disease (AD). Our laboratory has shown that oral CBD treatment prevents cognitive impairment in a male genetic mouse model of AD, the amyloid precursor…
read more here.
Keywords:
appxps1 mice;
mouse model;
mouse;
cbd ... See more keywords